No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Malignant neoplasm of nasopharynx based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of nasopharynx
- Malignant neoplasm of head and neck
- Malignant neoplasm of lip, oral cavity and pharynx
- Malignant neoplasm
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 860 | 287 | 554 |
Only index persons | 426 | 152 | 274 |
Unadjusted period prevalence (%) | |||
Whole population | 0.01 | 0.01 | 0.02 |
Only index persons | 0.01 | 0.01 | 0.01 |
Median age at first event (years) | |||
Whole population | 58.86 | 61.31 | 57.47 |
Only index persons | 58.25 | 59.21 | 57.72 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 89 | 38 | 51 |
Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.03 |
Median age at first event (years) | 62.14 | 57.12 | 65.88 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint C3_NASOPHARYNX_EXALLC and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
C3_NASOPHARYNX_EXALLC | 5.957 [2.67, 13.3] | < 0.001 |
Birth year | 0.992 [0.98, 1.0] | 0.063 |
During the follow-up period (1.1.1998 — 31.12.2019), 63 out of 137 females with C3_NASOPHARYNX_EXALLC died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
C3_NASOPHARYNX_EXALLC | 4.803 [3.38, 6.82] | < 0.001 |
Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 141 out of 279 males with C3_NASOPHARYNX_EXALLC died.
Mortality risk
Mortality risk for people of age
years, who have C3_NASOPHARYNX_EXALLC.N-year risk | Females | Males |
---|---|---|
1 | 0.351% | 0.716% |
5 | 2.809% | 5.366% |
10 | 7.504% | 13.218% |
15 | 14.172% | 24.424% |
20 | 23.777% | 38.34% |
Relationships between endpoints
↥Index endpoint: C3_NASOPHARYNX_EXALLC – Malignant neoplasm of nasopharynx
GWS hits: -